This message was sent to ##Email##
|
|
|
|
|
| |
AST
The AST Career Center connects hiring organizations and transplant professionals searching for career opportunities. AST members with openings to fill can post them here. For answers to questions about the Career Center, please visit: https://jobs.myast.org/.
AST
The AST will hold its second annual Transplant Community Summit during the Transplant Games of America in Salt Lake City, UT. The event will take place Aug. 2-7, 2018. If your patients will be attending the Transplant Games, please encourage them to visit the Power2Save booth and the Transplant Community Summit sessions.
AST
The AST is seeking applications for a directed grant on kidney biomarkers in collaboration with Astellas (deadline July 15). Also, the annual faculty development and fellowship grants are open now through November 1, 2018.
READ MORE
|
|
|
|
|
| |
AST
Spread the word about AST and all it has to offer to continue to strengthen the Society!
New this year - All members who successfully recruit 3 new members will receive 1 year of membership free! In addition, you will be entered into the yearly prize drawing, which includes an iPad or AST bucks!
Don't forget to mention - during July and August, the AST offers pro-rated dues amounts for new members. Trainees may join at just $45 and full members at just $270! View all rates here.
Quickly send your colleagues a professional request to join via our easy referral form.
Spread the word! Recommend colleagues for membership and earn rewards! Visit the Member-Get-A-Member page for program details and other resources.
AST
Registration for the 2018 Fellows Symposium in Transplantation is open now through August 8. For information and eligibility requirements, click here.
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career – from basic trainee lessons to webinars on specialized topics. Learn more.
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
AST
AST/AJT Journal Club
"Mood, Body Image, Fear of Kidney Failure, Life Satisfaction, and Decisional Stability Following Living Kidney Donation: Findings from the KDOC Study"
August 7, 2018 | 2 pm ET | Online Activity
For more information, click here.
AST
Epitope Matching in Kidney Allocation
After participating in this webinar, the learner will be able to:
- Describe epitopes in the context of transplantation.
- Discuss the importance of epitopes in HLA compatibility and optimizing graft outcome.
- Summarize how to potentially use "epitope tools" in HLA antibody analysis and matching of donors and recipients pairs.
READ MORE
FDA
On September 27-28 2018, the FDA Division of Transplant and Ophthalmology Products (DTOP) is hosting a two-day public workshop at the White Oak Campus in Silver Spring, MD entitled, Evidence-Based Treatment Decisions in Transplantation – The Right Dose for the Right Patient: Individualized Treatment. This collaborative workshop will be hosted in partnership with the Transplant Therapeutics Consortium and registration information will be announced ahead of the meeting through the Federal Register. To receive more information when it becomes available, click here.
| SRTR: Spring 2018 OSRs Upcoming Release, PSRs Delay
|
    |
AST
The spring 2018 OPO-specific reports (OSRs) will be released according to SRTR’s previously anticipated timeline. The secure preview will occur on 7/16/18, and the public release will occur on 8/9/2018. However, the release of the program-specific reports (PSRs) is postponed at this time.
As soon as the updated information becomes available, SRTR will announce the PSR release timeline. At that time, SRTR will also offer updated SAFs for researchers who received a SAF release from September 2017, December 2017, March 2018, or June 2018.
This missing information also potentially affects the 2017 Annual Data Report (ADR) development. The anticipated publication date is not available at this time, but we will alert the public as soon as a date is available.
ASN
Despite the burdensome symptoms experienced by dialysis patients, no drug or device has been approved by the FDA that improves any patient reported outcome. To address this challenge, the "Prioritizing Symptoms of ESRD Patients for Developing Therapeutic Interventions" Project was initiated in 2016. The project has two phases. The first phase of the project confirmed and prioritized the symptoms experienced by patients with kidney failure. The second phase used that information to convene a workshop with industry representatives, patients and health care professionals, and academia representatives and stakeholders from outside the nephrology space to determine if any existing products could address patient symptoms and improve patient quality of life.
ASN
Present your late-breaking research to 13,000 kidney professionals at the world's premier nephrology meeting. ASN is now accepting late-breaking clinical trial submissions online through Wednesday, September 5 (2:00 p.m. EDT). Submissions should discuss randomized Phase II and III trials that will have significant impact on clinical practice.
READ MORE
Transplantation
The best approach for determining whether a transplant program is delivering high-quality care is unknown. This review aims to identify and characterize quality metrics in solid organ transplantation.
READ MORE
Journal of the American Academy of Dermatology
The aim of this study was to investigate the dermatologic manifestations and clinical outcomes of SOT GVHD. After full-text article review, we included 61 articles, representing 115 patients and 126 transplanted organs. The most commonly transplanted organ was the liver (n = 81).
READ MORE
Nature Reviews Nephrology
The human major histocompatibility complex is a family of genes that encodes HLAs, which have a crucial role in defence against foreign pathogens and immune surveillance of tumours. In the context of transplantation, HLA molecules are polymorphic antigens that comprise an immunodominant alloreactive trigger for the immune response, resulting in rejection. Remarkable advances in knowledge and technology in the field of immunogenetics have considerably enhanced the safety of transplantation.
READ MORE
Transplantation Proceedings
Portal vein thrombosis (PVT) is a relatively common finding in patients undergoing liver transplantation. Although the recommendation to prevent its recurrence is anticoagulation during 3-6 months, this is controversial. The aim of our study was to determine the efficacy of oral anticoagulants (OAC) in the prophylaxis of recurrent PVT after liver transplantation.
READ MORE
Transplant Infectious Disease
Pre‐transplant cytomegalovirus (CMV) serostatus has been associated with lung transplant patient survival. We retrospectively analyzed the relationship between pre‐transplant donor/recipient CMV serostatus and long‐term mortality in a cohort of lung transplant recipients at our center.
READ MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
